National Academies reported COVID-19 vaccines don’t cause many potential harms
On Apr. 16, 2024, the National Academies of Sciences, Engineering, and Medicine reported that the COVID-19 vaccines made…
-
-
U.S. FDA announced revisions JNJ COVID-19 Vaccine fact sheets to include information pertaining to Guillain-Barre Syndrome
On Jul. 12, 2021, the Food and Drug Administration (FDA) announced revisions to the vaccine recipient and vaccination…
-
No association found between COVID-19 and Guillain-Barre syndrome
On Dec.14, 2020, neuroscientists at University College London (UCL) announced they had found no significant association between COVID-19…
-
Biotechnology | COVID-19 | Disease | Therapeutics | Vaccine
Relation between COVID-19 and Guillain-Barre syndrome in adults: a systematic review published
On Oct. 8, 2020, the relation between COVID-19 and Guillain-Barre syndrome in adults: a systematic review was published…
-
Biotechnology | CDC | Diagnostics | FDA | Infectious Disease | Neurology
FDA authorized marketing of first diagnostic test for detecting Zika virus antibodies
On May 23, 2019, the U.S. Food and Drug Administration (FDA) authorized marketing of a diagnostic test to…
-
swine flu vaccination program in the U.S. Suspended following reports of paralysis
On Oct. 13, 1976, the swine flu vaccination program in the U.S. was suspended following reports of paralysis. …
-
national immunization program for swine flu and Guillain-Barre syndrome Cause is Unknown
In 1976, the U.S. Centers for Disease Control and Prevention (CDC) was involved in a national immunization program…
-
Guillain-Barr syndrome, also known as Landry-Guillain-Barr-Strohl syndrome, was described
In 1916, Guillain-Barr syndrome (GBS), also known as Landry-Guillain-Barr-Strohl syndrome, was described. Its incidence in North America and…
